Latest Accounting News

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Aguia Resources has commenced underground mining at its Santa Barbara gold project and secured a key court victory for its Brazilian phosphate project, supported by a $1.5 million capital raise.

AGUIA RESOURCES LTD posted a $1.31 million net cash outflow for the December 2024 quarter, driven by exploration and evaluation expenses, while preparing for underground operations at its Santa Barbara Mine.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Gibb River Diamonds secures key agreements to progress gold mining at Edjudina and gains international exposure for its Ellendale Diamond Project, positioning itself for growth across multiple mineral fronts.

Po Valley Energy Limited reports a robust December 2024 quarter marked by rising gas production, strong revenue growth, and significant progress in exploration and development across its Italian assets.

Far Northern Resources reports promising assay results from its Rocks Reef and Empire projects in North Queensland, setting the stage for intensified exploration and drilling activities in 2025.

Flynn Gold Limited has announced a maiden Exploration Target at its Golden Ridge Project in Tasmania, estimating up to 520,000 ounces of contained gold, alongside a new exploration licence near the Beaconsfield Gold Mine.

Golden Horse Minerals Ltd posted a CAD 413,000 net cash outflow from operating activities in the December 2024 quarter, while maintaining a robust cash balance of CAD 13.37 million. The company’s cash burn reflects ongoing exploration and evaluation investments.

Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.

IVE Group Limited has scheduled its half-year financial results release for February 24, 2025, alongside a notable governance change with Paul Selig moving from Executive to Non-Executive Director.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.